Dr. Dino PratoEnvita Medical Centers · Founder and CEO at Envita Medical Centers

Here’s the truth most people don’t hear… #shorts

21 Feb 2026 · 1 min

Watch on YouTube

0:41

In this short, the speaker critiques standard cancer treatments for achieving only short‑term local tumor control and failing to produce lasting remission. He introduces the Symphonics program, which combines precisely targeted ultrasound (sound waves) with nanoparticle phytotherapeutic agents delivered directly to the tumor. The ultrasound rapidly destroys cancer cells while sparing healthy tissue, creating a rich tumor lysate. This lysate, together with the phytotherapeutic nanoparticles, is intended to act as an in‑situ vaccine, stimulating a systemic immune response and achieving immunotherapy synergy. The approach is guided by deep molecular testing of the tumor’s resistant pathways to tailor the treatment.

Chapters

Here's the truth most people don't hear a lot of cancer treatment is great at local control, meaning it can shrink a tumor maybe a little bit, but it doesn't have that long term response we want. Otherwise people would go into remission and stay there. Symphonics is designed using the sound waves to kill the cancer quickly in precision where it spares the healthy tissue. So in the Symphonics program that our team is working on, the goal is immunotherapy synergy. We use deep testing to look at the tumor, all the resistant pathways. Now we can use nanoparticle phytotherapeutics direct to the tumor prior to the use of the ultrasound, with the goal of killing the cancer, having a very rich lysate and using it in other parts of the body to stimulate the immune system.